Such an epitope is detrimental in MS; as it not only binds the HLA-DRB1 ∗1501 encoded HLA-DR2 molecule but also activates T cells from MS patients and causes illness in HLADRB1 ∗1501–transgenic mice [169]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.